Ikarian Capital, LLC 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 5:33 pm Purchase | 2025-03-31 | 13G | Avalo Therapeutics, Inc. AVTX | Ikarian Capital, LLC | 1,191,957 9.990% | 221,598 (+22.84%) | Filing |
| 2024-10-07 8:06 pm Purchase | 2024-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | Ikarian Capital, LLC | 970,359 10.020% | 970,359 (New Position) | Filing |